Form 8-K Akari Therapeutics Plc For: May 29
falsetrue00015411570001541157dei:AdrMember2024-05-292024-05-2900015411572024-05-292024-05-290001541157aktx:OrdinarySharesParValue0.0001PerShareMember2024-05-292024-05-29
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of theSecurities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 29, 2024
Akari Therapeutics, Plc
Form 144 Fiverr International Filed by: Kaufman Micha
html,body,div,span,applet,object,iframe,h1,h2,h3,h4,h5,h6,p,blockquote,pre,a,abbr,acronym,address,big,cite,code,del,dfn,em,font,img,ins,kbd,q,s,samp,small,strike,strong,sub,sup,tt,var,dl,dt,dd,ol,ul,li,fieldset,form,label,legend,table,caption,tbody,tfoot,thead,tr,th,td
{
margin: 0;
padding: 0;
border: 0;
outline: 0;
font-weight: inherit;
font-style: inherit;
font-size: 100%;
font-family: inherit;
vertical-align:... (continue reading...)
Form 8-K Keros Therapeutics, Inc. For: Jun 04
0001664710FALSE00016647102024-06-042024-06-04 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 4, 2024 Keros Therapeutics, Inc. (Exact name of registrant as specified in its charter) Delaware 001-39264 81-1173868(state or other jurisdictionof incorporation) (CommissionFile Number) (I.R.S.... (continue reading...)
Form 8-K Equillium, Inc. For: Jun 04
NASDAQ false 0001746466 0001746466 2024-06-04 2024-06-04
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 4, 2024
Equillium, Inc.
(Exact name of Registrant as Specified in Its Charter)
Delaware 001-38692 82-1554746
(State or Other... (continue reading...)
Form 424B2 PROVINCE OF BRITISH COLU
TABLE OF CONTENTS
The information in this prospectus supplement is not complete and may be changed. This prospectus supplement and the accompanying prospectus are not an offer to sell and are not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
Filed pursuant to Rule 424(b)(2) of the Securities Act of... (continue reading...)
More SEC Filings
View Older Stories-
Form DEFM14A Eliem Therapeutics, Inc.
-
Form 8-K Aon plc For: May 30
-
Form 424B5 Phunware, Inc.
-
Form 424B5 Neonode Inc.
-
Form 4 GE HealthCare Technologi For: Jun 01 Filed by: SACCARO JAMES
-
Form 6-K Genius Group Ltd For: Jun 04
-
Form 8-K SAIA INC For: Jun 04
-
Form 6-K New Gold Inc. /FI For: Jun 04
-
Form 8-K Designer Brands Inc. For: Jun 04
-
Form D BI-0422 Fund I, a series
-
Form 144 Canadian Solar Inc. Filed by: Chang Huifeng
-
Form D HO-0528 Fund III, a seri
-
Form 8-K LABCORP HOLDINGS INC. For: Jun 04
-
Form 8-K Frontdoor, Inc. For: Jun 03
-
Form PRER14C Astra Space, Inc.
-
Form C FLO NNN Real Yield LLC
-
Form 8-K FIRSTENERGY CORP For: Jun 04
-
Form D H3-0504 Fund I, a series
-
Form 8-K 5E Advanced Materials, For: Jun 03
-
Form 6-K IMMUTEP Ltd For: Jun 03
-
Form 8-K RESIDEO TECHNOLOGIES, For: Jun 04
-
Form 10-Q Core & Main, Inc. For: Apr 28
-
Form 424B7 BioXcel Therapeutics,
-
Form 8-K AMARIN CORP PLC\UK For: Jun 03
-
Form 6-K Itau Unibanco Holding For: Dec 31
-
Form 8-K Core & Main, Inc. For: Jun 04
-
Form D ME-0415 Fund II, a serie
-
Form D MileBreaker Partners
-
Form 8-K EYENOVIA, INC. For: Jun 04
-
Form C/A Kazark, Inc.
-
Form 8-K Fortrea Holdings Inc. For: Jun 03
-
Form 4 Rekor Systems, Inc. For: May 31 Filed by: Mehta Viraj
-
Form 8-K Bath & Body Works, Inc. For: Jun 04
-
Form 3 Rekor Systems, Inc. For: May 16 Filed by: Mehta Viraj
-
Form 8-K ESSENTIAL PROPERTIES For: Jun 04
-
Form D AR-0513 Fund I, a series
-
Form 8-K Viking Therapeutics, For: Jun 04
-
Form SC 13D/A Bitfarms Ltd Filed by: Riot Platforms, Inc.
-
Form D WA-0430 Fund I, a series
-
Form 425 SANUWAVE Health, Inc. Filed by: SANUWAVE Health, Inc.
-
Form 6-K Trip.com Group Ltd For: Jun 04
-
Form 8-K Annexon, Inc. For: Jun 04
-
Form 8-K SANUWAVE Health, Inc. For: Jun 03
-
Form 8-K Evolent Health, Inc. For: Jun 04
-
Form 425 Aquaron Acquisition Corp Filed by: Aquaron Acquisition Corp.
-
Form 425 SEP Acquisition Corp. Filed by: SEP Acquisition Corp.
-
Form 6-K Trip.com Group Ltd For: Jun 04
-
Form 8-K REALTY INCOME CORP For: Jun 04
-
Form 8-K Altair Engineering Inc. For: Jun 03
-
Form 8-K Transocean Ltd. For: Jun 04
